SOLARA SPECIALTY HARLINGEN
1. Target Overview & Investment Thesis
SOLARA SPECIALTY HARLINGEN is a 82-bed suburban community hospital in CAMERON, TX with $45.6M in net patient revenue and a 8.7% operating margin. The hospital serves a payer mix of 31.8% Medicare, 0.0% Medicaid, and 68.2% commercial.
Thesis: Turnaround. Our ML models identify $3.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 8.7% to 16.0% (+736bps).
| Net Revenue HCRIS | $45.6M |
| Current EBITDA COMPUTED | $3.9M |
| Operating Margin COMPUTED | 8.7% |
| Occupancy HCRIS | 83.6% |
| Revenue / Bed COMPUTED | $556K |
| Net-to-Gross HCRIS | 13.8% |
| Distress Probability ML | 38.8% |
2. Market Context & Competitive Position
TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of 8.7% places it above the state median. Among 207 size-comparable peers (41-164 beds), the median margin is 2.0%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (41-164), prioritizing same-state peers. 207 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| SOLARA SPECIALTY HARLINGEN (Target) | TX | 82 | $45.6M | 8.7% |
| THE HEART HOSPITAL BAYLOR PLAN | TX | 109 | $464.6M | 25.7% |
| COLLEGE STATION HOSPITAL | TX | 135 | $397.7M | -0.9% |
| DECATUR COMMUNITY HOSPITAL | TX | 81 | $361.0M | -15.5% |
| CHILDRENS MEDICAL CENTER OF PL | TX | 72 | $336.7M | 20.9% |
| ROUND ROCK MEDICAL CENTER | TX | 161 | $296.7M | 25.7% |
| BAYLOR SW MEDICAL CENTER- WAXA | TX | 123 | $273.6M | 15.9% |
| BAYLOR HEART AND VASCULAR HOSP | TX | 53 | $255.0M | 30.0% |
| BAYLOR S&W MEDICAL CENTER - PL | TX | 160 | $242.5M | 4.0% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.4M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $958K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $912K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $903K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $555K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $29K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $3.9M |
| + RCM Uplift | +$3.4M |
| Pro Forma EBITDA | $7.3M |
| Current Margin | 8.7% |
| Pro Forma Margin | 16.0% |
| WC Released (1x) | $1.7M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $6.1M | $59.6M | 9.81x | 57.9% |
| Base (11x exit) | 10.0x | 11.0x | $6.1M | $67.5M | 11.12x | 61.9% |
| Bull Case | 9.0x | 11.0x | $5.5M | $80.6M | 14.74x | 71.3% |
| Bull (12x exit) | 9.0x | 12.0x | $5.5M | $89.5M | 16.38x | 74.9% |
| Bear Case | 11.0x | 10.0x | $6.7M | $40.9M | 6.11x | 43.6% |
| Bear (11x exit) | 11.0x | 11.0x | $6.7M | $47.1M | 7.05x | 47.8% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 207 hospitals with 41-164 beds
- Same-state prioritization (n=208)
- Comp margins: P25=-11.3% / P50=2.0% / P75=11.7%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.